References
WHO. Global Tuberculosis Report. WHO; 2013. p. 1–30.
WHO/IUALTD. Global Project on Anti tuberculosis Drug Surveillance in the World Report No. 3. Anti tuberculosis Drug Resistance in the World WHO/HTM/TB/2004.343. Geneva: World Health Organization; 2004.
Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575–80.
Sharma SK, Mohan A. The implications of multidrug resistant tuberculosis. Eur Infect Dis 2007;1:52–4.
Tuli SM. Tuberculosis of the Skeletal System. 4th ed. New Delhi: JP Brothers Medical Publishers; 2010. p. 18–30.
WHO. Treatment of Tuberculosis: Guidelines for National Programmes. 4th ed. WHO. p. 84–92.
Hobby GL, Johnson PM, Boytar-Papirnyik V. Primary drug resistance: A continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. Primary drug resistance: A continuing study of drug resistance in tuberculosis in a veteran population within the United States 1974;110:95–8.
Stanford JL, Stanford CA. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659. Immunobiology 1994;191:555–63.
Tomioka H. Adjunctive immunotherapy of mycobacterial infections. Curr Pharm Des 2004;10:3297–312.
Tuli SM. Preliminary observations on the effect of immunomodulation in multidrug resistant cases of osteoarticular tuberculosis. Indian J Orthop 1999;33:83–5.
Arora A, Nadkarni B, Dev G, Chattopadhya D, Jain AK, Tuli SM, et al. The use of immunomodulators as an adjunct to anti tuberculous chemotherapy in nonresponsive patients with osteo-articular tuberculosis. J Bone Joint Surg Br 2006;88:264–9.
Setia MS, Steinmaus C, Ho CS, Rutherford GW. The role of BCG in prevention of leprosy: A meta-analysis. Lancet Infect Dis 2006;6:162–70.
Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect Immun 2001;69:5403–11.
Tuli SM. Challenge of therapeutically refractory and multidrug resistance tuberculosis in orthopaedic patients. Indian J Orthop 2002;36:211–3.
McShane H. Tuberculosis vaccines: Beyond bacille Calmette-Guerin. Philos Trans R Soc Lond B Biol Sci 2011;366:2782–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tuli, S.M. Multidrug resistant tuberculosis: A challenge in clinical orthopedics. IJOO 48, 235–237 (2014). https://doi.org/10.4103/0019-5413.132487
Published:
Issue Date:
DOI: https://doi.org/10.4103/0019-5413.132487